I agree that this site is using cookies. You can find further informations here.
X
Stefanizzi, Caterina
37  results:
Search for persons X
?
1

Correspondence in reference to the previously published man..:

Autore, Francesco ; Fresa, Alberto ; Innocenti, Idanna...
Hematological Oncology.  41 (2022)  3 - p. 571-573 , 2022
Link: https://doi.org/10.1002/..
 
?
2

Independent prognostic impact of CD15 on complete remission..:

Chisini, Marta ; Stefanizzi, Caterina ; Ceglie, Teresa...
Hematological Oncology.  35 (2016)  4 - p. 804-809 , 2016
Link: https://doi.org/10.1002/..
 
?
3

Risk of secondary hypogammaglobulinaemia after Rituximab an..:

De Angelis, Federico ; Tosti, Maria Elena ; Capria, Saveria...
Leukemia Research.  39 (2015)  12 - p. 1382-1388 , 2015
Link: https://doi.org/10.1016/..
 
?
4

Negative prognostic value of CD34 antigen also if expressed..:

Breccia, Massimo ; De Propris, Maria Stefania ; Stefanizzi, Caterina...
Annals of Hematology.  93 (2014)  11 - p. 1819-1823 , 2014
Link: https://doi.org/10.1007/..
 
?
5

Aberrant phenotypic expression of CD15 and CD56 identifies ..:

Breccia, Massimo ; De Propris, Maria Stefania ; Minotti, Clara...
Leukemia Research.  38 (2014)  2 - p. 194-197 , 2014
Link: https://doi.org/10.1016/..
 
?
6

Regression of a case of Multiple Myeloma with antiviral tre..:

Panfilio, Sara ; D'Urso, Pasqualina ; Annechini, Giorgia...
Leukemia Research Reports.  2 (2013)  1 - p. 39-40 , 2013
Link: https://doi.org/10.1016/..
 
?
7

ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVA..:

Meloni, Giovanna ; Foà, Robin ; Micozzi, Alessandra...
Mediterranean Journal of Hematology and Infectious Diseases.  4 (2012)  1 - p. e2012072 , 2012
Link: https://doi.org/10.4084/..
 
?
8

"Real-life" results of front-line treatment with Imatinib i..:

Latagliata, Roberto ; Breccia, Massimo ; Carmosino, Ida...
Leukemia Research.  34 (2010)  11 - p. 1472-1475 , 2010
Link: https://doi.org/10.1016/..
 
?
9

Sequential development of mutant clones in an imatinib resi..:

Breccia, Massimo ; Frustaci, Anna Maria ; Cannella, Laura...
Cancer Chemotherapy and Pharmacology.  64 (2009)  1 - p. 195-197 , 2009
Link: https://doi.org/10.1007/..
 
?
10

Cytogenetic and molecular responses in chronic phase chroni..:

Breccia, Massimo ; Cannella, Laura ; Stefanizzi, Caterina...
Hematological Oncology.  28 (2009)  2 - p. 89-92 , 2009
Link: https://doi.org/10.1002/..
 
?
11

Unusual association of paroxysmal cold hemoglobinuria as th..:

Stefanizzi, Caterina ; Breccia, Massimo ; Santopietro, Michelina...
International Journal of Hematology.  89 (2009)  5 - p. 720-721 , 2009
Link: https://doi.org/10.1007/..
 
?
12

Comorbidities and FLT3‐ITD abnormalities as independent pro..:

Breccia, Massimo ; Frustaci, Anna Maria ; Cannella, Laura...
Hematological Oncology.  27 (2009)  3 - p. 148-153 , 2009
Link: https://doi.org/10.1002/..
 
?
13

Achievement of complete molecular responses in late chronic..:

Breccia, Massimo ; Cannella, Laura ; Stefanizzi, Caterina...
Leukemia Research.  33 (2009)  5 - p. 645-648 , 2009
Link: https://doi.org/10.1016/..
 
?
14

Decisional flow with a scoring system to start platelet-low..:

Latagliata, Roberto ; Rago, Angela ; Spadea, Antonio...
International Journal of Hematology.  90 (2009)  4 - p. 486-491 , 2009
Link: https://doi.org/10.1007/..
 
?
15

WPSS versus simplified myelodysplastic syndrome risk score:..:

Breccia, Massimo ; Cannella, Laura ; Stefanizzi, Caterina...
Leukemia Research.  33 (2009)  7 - p. e93-e94 , 2009
Link: https://doi.org/10.1016/..
 
1-15